U.S. Expects “American Standards” From Food, Drug Pacts With China
This article was originally published in The Tan Sheet
Agreements reached Dec. 11 will ensure that Chinese food and drug products imported to the U.S. are produced "in accordance with American standards of quality and safety," according to Health and Human Services Secretary Michael Leavitt
You may also be interested in...
China aims to upgrade supervision of its entire health care sector with an array of regulatory changes for pharmaceuticals and medical devices likely this year, including good manufacturing practice guidelines, according to a leading lawyer in the area of China's life sciences-related issues and legislation
FDA and the pharmaceutical industry have some catching up to do to mitigate the import safety and counterfeiting risks amplified by the globalization of supply chains, says the agency's policy chief
The reorganization of China's State Food and Drug Administration should create a "really good opportunity" for the dietary supplement industry, says Jeff Crowther, director of the Natural Products Association's office in China